RNA, Cell, Protein, And Vector Engineering
We have centralized RNA, cell, protein, and vector engineering to improve productivity and scalability and to ensure external partners and internal programs have access to the necessary tools to build novel therapies.
Enabling the manufacturing, development and design of cell and gene therapies through engineering.
Engineering at the Center of Cell and Gene Therapy Innovation
We have built multiple engineering technology platforms that are essential to the construct, design, and scaling of cell and gene therapies. Through our engineering technologies, we have centralized these technologies to ensure internal programs and external partners have access to the necessary tools to build novel therapies.
An Integrated Ecosystem of Engineering Technology
Each engineering platform is fully integrated within the ElevateBio® ecosystem to improve productivity and scalability of the therapies we develop and manufacture.
RNA Engineering
We are developing novel technologies to deliver RNA molecules to cells to provide genetic instructions to make specific proteins, which can treat or prevent disease, or to disrupt the production of disease-causing proteins.
Cellular Engineering
We have developed multiple platforms aimed at overcoming the immunosuppressive tumor microenvironment and enhancing immune cell function and proliferation in cell therapies.
Protein Engineering
Our protein engineering platform can help improve the efficiency and specificity of new technologies, including the continued advancement of antigen receptors, binders, and endonucleases.
Vector Engineering
Our viral vector engineering technologies can support all stages of development, including gene delivery and end-to-end process development and manufacturing for lentiviral and adeno-associated virus (AAV) vectors, across different cell types and payloads.
Our Integrated Technology Platforms: Fueling the Discoveries of Tomorrow
Gene Editing
We have a powerful suite of proprietary gene editing technologies to accelerate the development of life-changing and curative therapies for patients. Click here to learn about gene editing.
Induced Pluripotent Stem Cells (iPSCs)
We are setting a new standard with well-characterized induced pluripotent stem cell (iPSC) lines that are suitable for research, clinical and commercial use. Click here to learn about iPSCs.
Partner with ElevateBio®
Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.